Research Solutions Inc Aktie News

Research Solutions, Inc. (NASDAQ:RSSS ) Q3 2024 Results Conference Call May 9, 2024 5:00 PM ET Company Participants John Beisler - Three Part Advisors, Investor Relations Roy Olivier - President & Chief Executive Officer Bill Nurthen - Chief Financial Officer Conference Call Participants Jacob Stephan - Lake Street Allen Klee - Maxim Group Operator Good day, ladies and gentlemen, and welcome to...

Reports 17% Revenue Increase, ARR of $16.6 Million Positive Net Income and Record Adjusted EBITDA HENDERSON, Nev. , May 9, 2024 /PRNewswire/ --   Research Solutions, Inc. (NASDAQ: RSSS), a trusted partner providing cloud-based workflow solutions to accelerate research for R&D-driven organizations, reported financial results for its fiscal third quarter ended March 31, 2024.

HENDERSON, Nev. , April 30, 2024 /PRNewswire/ --  Research Solutions, Inc.  (NASDAQ: RSSS), a pioneer in providing cloud-based workflow solutions for R&D driven organizations, will hold a conference call to discuss its financial results for the fiscal 2024 third quarter ended March 31, 2024, on Thursday, May 9, 2024, at 5:00 p.m.

LOUISVILLE, Colo.--(BUSINESS WIRE)--Alchemer, a global leader in experience management and enterprise feedback technology, today announced the launch of Alchemer Research Solutions, a full-service market research team available to help customers quickly expand and scale their research capabilities to ensure they get the insights they need. Led by long-time industry veteran, Brian Henley, Alchem...

Powerful AI, combined with comprehensive data, simplifies the discovery and synthesis of clinical trial information to accelerate innovation in the medical field HENDERSON, Nev. , April 15, 2024 /PRNewswire/ -- Research Solutions (NASDAQ: RSSS), a trusted partner providing cloud-based workflow solutions to accelerate research for R&D-driven organizations, today launches their new Clinical Trial...

CHICAGO--(BUSINESS WIRE)--Heart Rhythm Clinical and Research Solutions (HRCRS) and the Real World Evidence (RWE) Consortium have enrolled the first patient in the REView of ProcEdural FactoRs and Outcomes after Atrial Fibrillation Ablation with Active Esophageal COOLing (EVERCOOL AF) study. The study is part of a multi-center observational study evaluating the impact of proactive esophageal coo...

Nvidia's (NASDAQ: NVDA ) recent AI conference showcased some impressive new technology, including the company's expensive new AI chip that purportedly outperforms all other AI chips on the market. However, the hype did not translate into a meaningful stock price increase, as many investors believe the company's growth potential is already priced into its lofty market capitalization.

AI-powered software module enables production of reports in minutes to save months of manual analysis HENDERSON, Nev. , Feb. 15, 2024 /PRNewswire/ -- Research Solutions (NASDAQ: RSSS), a trusted partner providing cloud-based workflow solutions to accelerate research for R&D-driven organizations, today launches their new Technology Landscape Module.